English | Español
Patient Daily | Sep 27, 2023

Dr. Stephen Stahl: 'EXXUA is the first truly selective agonist of the serotonin 1a receptor that has been consistently linked to mediation of mood disorders and suicide risk'
Patient Daily | Sep 27, 2023

CDC Director Dr. Cohen: 'I strongly encourage you and your family to get the immunizations that are right for you'
Patient Daily | Sep 27, 2023

Laura Davis Jones: 'I firmly believe that early detection is within our reach'
Patient Daily | Sep 27, 2023

Natalie Eberhardt, PhD: 'Our findings provide for the first time a direct mechanistic link between COVID-19 infection and the heart complications it provokes'
Patient Daily | Sep 24, 2023

Trust for America's Health: 'It's critical to recognize that obesity is a multifactored disease involving much more than individual behavior'
Patient Daily | Sep 24, 2023

ARS Pharma CEO: 'We are deeply disappointed that this action further delays the availability of 'neffy' for the millions of people who are at risk of a potentially life-threatening severe allergic...
Patient Daily News Service | Sep 23, 2023

Dallas Breathe-Free Sinus & Allergy Centers surpasses 380 Google reviews, 4.7-star rating
Patient Daily News Service | Sep 21, 2023

Arizona Breathe-Free Sinus & Allergy Centers surpasses 100 Google reviews, hits almost-perfect score

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’